227 related articles for article (PubMed ID: 9605089)
1. Heparinless cardiopulmonary bypass with active-site blocked factor IXa: a preliminary study on the dog.
Spanier TB; Oz MC; Minanov OP; Simantov R; Kisiel W; Stern DM; Rose EA; Schmidt AM
J Thorac Cardiovasc Surg; 1998 May; 115(5):1179-88. PubMed ID: 9605089
[TBL] [Abstract][Full Text] [Related]
2. Selective anticoagulation with active site-blocked factor IXA suggests separate roles for intrinsic and extrinsic coagulation pathways in cardiopulmonary bypass.
Spanier TB; Chen JM; Oz MC; Edwards NM; Kisiel W; Stern DM; Rose EA; Schmidt AM
J Thorac Cardiovasc Surg; 1998 Nov; 116(5):860-9. PubMed ID: 9806393
[TBL] [Abstract][Full Text] [Related]
3. Selective anticoagulation with active site blocked factor IXa in synthetic patch vascular repair results in decreased blood loss and operative time.
Spanier TB; Oz MC; Madigan JD; Rose EA; Stern DM; Nowygrod R; Schmidt AM
ASAIO J; 1997; 43(5):M526-30. PubMed ID: 9360098
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of factor IXa by the pegnivacogin system during cardiopulmonary bypass: a potential substitute for heparin. A study in baboons.
Bel A; Borik W; Davidson S; Helies JM; Stimmer L; Fremes S; Zelenkofske S; Rusconi C; Alexander J; Alexander D; Menasché P; Pepper J
Eur J Cardiothorac Surg; 2016 Feb; 49(2):682-9. PubMed ID: 25953802
[TBL] [Abstract][Full Text] [Related]
5. Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model.
Benedict CR; Ryan J; Wolitzky B; Ramos R; Gerlach M; Tijburg P; Stern D
J Clin Invest; 1991 Nov; 88(5):1760-5. PubMed ID: 1939660
[TBL] [Abstract][Full Text] [Related]
6. A novel antidote-controlled anticoagulant reduces thrombin generation and inflammation and improves cardiac function in cardiopulmonary bypass surgery.
Nimjee SM; Keys JR; Pitoc GA; Quick G; Rusconi CP; Sullenger BA
Mol Ther; 2006 Sep; 14(3):408-15. PubMed ID: 16765093
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of aprotinin with various anticoagulant agents in cardiopulmonary bypass.
Terrell MR; Walenga JM; Koza MJ; Pifarré R
Ann Thorac Surg; 1996 Aug; 62(2):506-11. PubMed ID: 8694614
[TBL] [Abstract][Full Text] [Related]
8. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
[TBL] [Abstract][Full Text] [Related]
9. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
[TBL] [Abstract][Full Text] [Related]
10. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of arterial thrombosis by a soluble tissue factor mutant and active site-blocked factors IXa and Xa in the guinea pig.
Himber J; Refino CJ; Burcklen L; Roux S; Kirchhofer D
Thromb Haemost; 2001 Mar; 85(3):475-81. PubMed ID: 11307818
[TBL] [Abstract][Full Text] [Related]
12. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
[TBL] [Abstract][Full Text] [Related]
14. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass.
Shigeta O; Kojima H; Hiramatsu Y; Jikuya T; Terada Y; Atsumi N; Sakakibara Y; Nagasawa T; Mitsui T
J Thorac Cardiovasc Surg; 1999 Aug; 118(2):354-60. PubMed ID: 10425010
[TBL] [Abstract][Full Text] [Related]
15. An Adjusted Calculation Model Allows for Reduced Protamine Doses without Increasing Blood Loss in Cardiac Surgery.
Kjellberg G; Sartipy U; van der Linden J; Nissborg E; Lindvall G
Thorac Cardiovasc Surg; 2016 Sep; 64(6):487-93. PubMed ID: 26270199
[TBL] [Abstract][Full Text] [Related]
16. Heparinless cardiopulmonary bypass with argatroban in dogs.
Rikitake K; Okazaki Y; Naito K; Ohtsubo S; Natsuaki M; Itoh T
Eur J Cardiothorac Surg; 2004 May; 25(5):819-24. PubMed ID: 15082288
[TBL] [Abstract][Full Text] [Related]
17. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
[TBL] [Abstract][Full Text] [Related]
18. Argatroban as a potential anticoagulant in cardiopulmonary bypass-studies in a dog model.
Sakai M; Ohteki H; Narita Y; Naitoh K; Natsuaki M; Itoh T
Cardiovasc Surg; 1999 Mar; 7(2):187-94. PubMed ID: 10353669
[TBL] [Abstract][Full Text] [Related]
19. Safety issues in heparin and protamine administration for extracorporeal circulation.
Jobes DR
J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
[TBL] [Abstract][Full Text] [Related]
20. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
Slight RD; Buell R; Nzewi OC; McClelland DB; Mankad PS
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):47-52. PubMed ID: 18249330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
